Search research articles
Contact Us
Filters
Showing results (181-190 of 197) with videos related to
Page
of 20
Sort By:
Lancet Regional Health. Americas
|
March 27, 2023
The impact of sustained malaria control in the Loreto region of Peru: a retrospective, observational, spatially-varying interrupted time series analysis of the PAMAFRO program
Mark M Janko, G Cristina Recalde-Coronel, Camila P Damasceno, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 25, 2006
A randomized phase II trial evaluating standard (50 mg/min) versus low (10 mg/min) infusion duration of gemcitabine as first-line treatment in advanced non-small-cell lung cancer patients who are not eligible for platinum-based chemotherapy
F Cappuzzo, S Novello, F De Marinis, et al.
Psychopathology
|
April 24, 2001
Early behavioral development in autistic children: the first 2 years of life through home movies
S Maestro, F Muratori, F Barbieri, et al.
European Journal of Neurology
|
June 30, 2012
Effect of glatiramer acetate on disease reactivation in MS patients discontinuing natalizumab
S Rossi, C Motta, V Studer, et al.
British Journal of Cancer
|
June 16, 2005
Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer
F Cappuzzo, S Novello, F De Marinis, et al.
Neurological Research and Practice
|
February 3, 2026
Collaborative neurocardiology board meetings for decision-making in stroke care: a real-world experience
V Mafael, T Buck, H Stengl, et al.
Neuroscience
|
June 4, 2013
Systemic treatment with adipose-derived mesenchymal stem cells ameliorates clinical and pathological features in the amyotrophic lateral sclerosis murine model
S Marconi, M Bonaconsa, I Scambi, et al.
Neurological Research and Practice
|
March 18, 2026
Correction: Collaborative neurocardiology board meetings for decision-making in stroke care: a real-world experience
V Mafael, T Buck, H Stengl, et al.
Neurology
|
April 26, 2006
Ataxia with oculomotor apraxia type 2: a clinical, pathologic, and genetic study
C Criscuolo, L Chessa, S Di Giandomenico, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 2, 2018
Primary resistance to osimertinib due to SCLC transformation: Issue of T790M determination on liquid re-biopsy
R Minari, P Bordi, M Del Re, et al.
Page
of 20
Search research articles
Search
Showing results (181-190 of 197) with videos related to
Sort By:
Page
of 20
Lancet Regional Health. Americas
|
March 27, 2023
The impact of sustained malaria control in the Loreto region of Peru: a retrospective, observational, spatially-varying interrupted time series analysis of the PAMAFRO program
Mark M Janko, G Cristina Recalde-Coronel, Camila P Damasceno, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 25, 2006
A randomized phase II trial evaluating standard (50 mg/min) versus low (10 mg/min) infusion duration of gemcitabine as first-line treatment in advanced non-small-cell lung cancer patients who are not eligible for platinum-based chemotherapy
F Cappuzzo, S Novello, F De Marinis, et al.
Psychopathology
|
April 24, 2001
Early behavioral development in autistic children: the first 2 years of life through home movies
S Maestro, F Muratori, F Barbieri, et al.
European Journal of Neurology
|
June 30, 2012
Effect of glatiramer acetate on disease reactivation in MS patients discontinuing natalizumab
S Rossi, C Motta, V Studer, et al.
British Journal of Cancer
|
June 16, 2005
Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer
F Cappuzzo, S Novello, F De Marinis, et al.
Neurological Research and Practice
|
February 3, 2026
Collaborative neurocardiology board meetings for decision-making in stroke care: a real-world experience
V Mafael, T Buck, H Stengl, et al.
Neuroscience
|
June 4, 2013
Systemic treatment with adipose-derived mesenchymal stem cells ameliorates clinical and pathological features in the amyotrophic lateral sclerosis murine model
S Marconi, M Bonaconsa, I Scambi, et al.
Neurological Research and Practice
|
March 18, 2026
Correction: Collaborative neurocardiology board meetings for decision-making in stroke care: a real-world experience
V Mafael, T Buck, H Stengl, et al.
Neurology
|
April 26, 2006
Ataxia with oculomotor apraxia type 2: a clinical, pathologic, and genetic study
C Criscuolo, L Chessa, S Di Giandomenico, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 2, 2018
Primary resistance to osimertinib due to SCLC transformation: Issue of T790M determination on liquid re-biopsy
R Minari, P Bordi, M Del Re, et al.
Page
of 20